Related Experiment Videos
[Ureteral and vesicular endometriosis: case report]
1Fédération de Gynécologie-Obstétrique, CHU La Grave, Toulouse, France.
Summary
This case study details vesical and ureteral endometriosis, a rare condition diagnosed after recurrent pyelonephritis. Treatment with Gonadotrophin-Releasing Hormone (GnRH) agonist therapy and endoscopic management led to lesion regression.
Area of Science:
- Urology
- Gynecology
- Reproductive Medicine
Background:
- Endometriosis is a condition where tissue similar to the uterine lining grows outside the uterus.
- Vesical and ureteral endometriosis are rare manifestations, often presenting with non-specific symptoms.
Observation:
- A patient presented with recurrent acute pyelonephritis, leading to the diagnosis of both vesical and ureteral endometriosis.
- This diagnosis was established despite the uncommon location of endometriosis, which accounts for only 1-2% of all cases.
Findings:
- Treatment involved Gonadotrophin-Releasing Hormone (GnRH) agonist therapy combined with conservative endoscopic management.
- This therapeutic approach resulted in an almost complete regression of the endometriotic lesions in the bladder and ureter.
Implications:
- Highlights the importance of considering endometriosis in the differential diagnosis of recurrent urinary tract infections and pyelonephritis, even in unusual locations.
- Demonstrates the efficacy of GnRH agonist therapy and conservative endoscopic management for treating rare forms of endometriosis.
- Underscores the need for further research into the pathogenesis and optimal management strategies for extragenital endometriosis.